F J Toro Prieto

Learn More
BACKGROUND The persistence of secondary hyperparathyroidism plays an important role in posttransplant bone loss. Calcimimetics are efficient to control metabolic alterations associated with this problem, but there are few publications that assess their effects on bone density. PATIENTS AND METHODS This prospective study assessed the effects of a single(More)
  • 1